Salazopyrin En-Tabs 500 mg 500 mg

Salazopyrin EN-Tabs 500 mg is an enteric-coated tablet containing sulfasalazine, used for managing inflammatory conditions. This medication is designed to provide targeted relief and is manufactured by Pfizer Canada ULC.

Salazopyrin EN-Tabs 500 mg is commonly used to manage inflammatory conditions such as rheumatoid arthritis and ulcerative colitis. Sulfasalazine, the active ingredient, helps reduce inflammation and alleviate symptoms associated with these conditions. It is often prescribed as part of a broader treatment plan to improve quality of life for individuals dealing with chronic inflammatory disorders.

Common effects of Salazopyrin EN-Tabs 500 mg may include nausea, vomiting, and headache. Some users might experience skin reactions or changes in urine color. These effects can vary from person to person, and it's important to monitor any unusual symptoms while taking this medication.

Salazopyrin EN-Tabs 500 mg should be handled with care, especially by individuals with known allergies to sulfasalazine or related compounds. It is advisable to consult a healthcare provider before starting this medication, particularly if you have any pre-existing conditions or are taking other medications. Always follow the prescribed dosage and storage instructions to ensure safety.

Salazopyrin EN-Tabs 500 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol consumption should be avoided as it can exacerbate potential side effects. It is crucial to inform your healthcare provider about all medications and supplements you are taking to avoid adverse interactions.